Patrick Robberecht

1.6k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Patrick Robberecht is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Patrick Robberecht has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Patrick Robberecht's work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (19 papers) and Peptidase Inhibition and Analysis (6 papers). Patrick Robberecht is often cited by papers focused on Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (19 papers) and Peptidase Inhibition and Analysis (6 papers). Patrick Robberecht collaborates with scholars based in Belgium and United Kingdom. Patrick Robberecht's co-authors include Magalì Waelbroeck, Philippe Gourlet, Illana Gozes, Sunil P. Sreedharan, Stephen R. Rawlings, Anthony J. Harmar, A. Arimura, Marc Laburthe, Joseph R. Pisegna and Sami I. Said and has published in prestigious journals such as FEBS Letters, European Journal of Biochemistry and Biochemical Pharmacology.

In The Last Decade

Patrick Robberecht

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

1998 648 citations Patrick Robberecht et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Robberecht Belgium	17	1.2k	902	231	199	169	22	1.4k
S.A. Wank United States	8	640 0.5×	523 0.6×	314 1.4×	209 1.1×	132 0.8×	9	1.2k
A. Arimura United States	8	674 0.6×	458 0.5×	122 0.5×	264 1.3×	176 1.0×	17	1.1k
Stephen R. Rawlings Switzerland	16	1.5k 1.2×	921 1.0×	178 0.8×	309 1.6×	520 3.1×	22	1.8k
B Amiranoff France	22	1.6k 1.4×	1.4k 1.6×	172 0.7×	560 2.8×	228 1.3×	40	1.9k
Philippe Gourlet Belgium	28	2.0k 1.6×	1.5k 1.6×	401 1.7×	386 1.9×	417 2.5×	56	2.2k
Terry W. Moody United States	14	658 0.5×	481 0.5×	218 0.9×	90 0.5×	82 0.5×	20	855
Katarina Bedecs Sweden	22	944 0.8×	1.0k 1.2×	72 0.3×	344 1.7×	166 1.0×	29	1.5k
Kazumi Koga Japan	11	448 0.4×	286 0.3×	64 0.3×	158 0.8×	71 0.4×	24	634
Steven Guard United Kingdom	16	764 0.6×	696 0.8×	59 0.3×	72 0.4×	39 0.2×	30	1.1k
Birgitte S. Wulff Denmark	18	313 0.3×	531 0.6×	65 0.3×	555 2.8×	73 0.4×	26	1.4k

Countries citing papers authored by Patrick Robberecht

Since Specialization

Citations

This map shows the geographic impact of Patrick Robberecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Robberecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Robberecht more than expected).

Fields of papers citing papers by Patrick Robberecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Robberecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Robberecht. The network helps show where Patrick Robberecht may publish in the future.

Co-authorship network of co-authors of Patrick Robberecht

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Robberecht. A scholar is included among the top collaborators of Patrick Robberecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Robberecht. Patrick Robberecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vandermeers‐Piret, Marie‐Claire, André Vandermeers, Philippe Gourlet, et al.. (2000). Evidence that the lizard helospectin peptides are O‐glycosylated. European Journal of Biochemistry. 267(14). 4556–4560. 6 indexed citations

Juarranz, Marı́a G., Jean Van Rampelbergh, Philippe Gourlet, et al.. (1999). Vasoactive intestinal polypeptide VPAC₁ and VPAC₂ receptor chimeras identify domains responsible for the specificity of ligand binding and activation. European Journal of Biochemistry. 265(1). 449–456. 23 indexed citations

Juarranz, Marı́a G., Jean Van Rampelbergh, Philippe Gourlet, et al.. (1999). Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands. Molecular Pharmacology. 56(6). 1280–1287. 5 indexed citations

Juarranz, Marı́a G., Jean Van Rampelbergh, Philippe Gourlet, et al.. (1999). Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC₂-Selective Ligands. Molecular Pharmacology. 56(6). 1280–1287. 29 indexed citations

Robberecht, Patrick, Philippe De Neef, & Romain A. Lefebvre. (1998). Influence of selective VIP receptor agonists in the rat gastric fundus. European Journal of Pharmacology. 359(1). 77–80. 30 indexed citations

Paolo, Emmanuel Di, Philippe De Neef, Nicole Moguilevsky, et al.. (1998). Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Letters. 424(3). 207–210. 45 indexed citations

Vilardaga, Jean‐Pierre, et al.. (1997). Mutational Analysis of Extracellular Cysteine Residues of Rat Secretin Receptor Shows that Disulfide Bridges are Essential for Receptor Function. European Journal of Biochemistry. 246(1). 173–180. 41 indexed citations

Gourlet, Philippe, Pascale Vertongen, André Vandermeers, et al.. (1997). The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass. Peptides. 18(3). 403–408. 129 indexed citations

Gourlet, Philippe, André Vandermeers, Patrick Robberecht, & M Deschodt-Lanckman. (1997). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11. Biochemical Pharmacology. 54(4). 509–515. 31 indexed citations

10.

Gourlet, Philippe, Jean‐Pierre Vilardaga, Philippe De Neef, et al.. (1996). Interaction of Amino Acid Residues at Positions 8–15 of Secretin with the N‐Terminal Domain of the Secretin Receptor. European Journal of Biochemistry. 239(2). 349–355. 37 indexed citations

11.

Gourlet, Philippe, André Vandermeers, Marie‐Claire Vandermeers‐Piret, et al.. (1996). Effect of introduction of an Arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1314(3). 267–273. 31 indexed citations

12.

Gourlet, Philippe, André Vandermeers, Marie‐Claire Vandermeers‐Piret, et al.. (1996). C-Terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors. Regulatory Peptides. 62(2-3). 125–130. 28 indexed citations

13.

Gourlet, Philippe, Jean‐Pierre Vilardaga, Philippe De Neef, et al.. (1996). The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides. 17(5). 825–829. 75 indexed citations

14.

Ciccarelli, E., Michal Svoboda, Philippe De Neef, et al.. (1995). Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells. European Journal of Pharmacology Molecular Pharmacology. 288(3). 259–267. 41 indexed citations

15.

Vertongen, Pascale, B. Velkeniers, Elisabeth L. Hooghe‐Peters, & Patrick Robberecht. (1995). Differential alternative splicing of PACAP receptor in pituitary cell subpopulations. Molecular and Cellular Endocrinology. 113(2). 131–135. 24 indexed citations

16.

Nilsson, Siv, Philippe De Neef, Patrick Robberecht, & Jean Christophe. (1994). Characterization of Ocular Receptors for Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and their Coupling to Adenylate Cyclase. Experimental Eye Research. 58(4). 459–467. 40 indexed citations

17.

Robberecht, Patrick, et al.. (1994). Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas. Regulatory Peptides. 52(1). 53–60. 2 indexed citations

18.

Robberecht, Patrick, et al.. (1989). Decreased adenylate cyclase activation by helodermin and PGE1 in the lectin-resistant variant Wa4 of the mouse melanoma cell line B16. Peptides. 10(5). 1075–1079. 4 indexed citations

19.

Waelbroeck, Magalì, et al.. (1987). Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.. Molecular Pharmacology. 32(1). 91–99. 57 indexed citations

20.

Robberecht, Patrick, et al.. (1982). Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.. Molecular Pharmacology. 21(3). 589–593. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact